Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Apiam Animal Health Ltd. ( (AU:AHX) ) is now available.
Apiam Animal Health Ltd. experienced a challenging FY25, with overall financial results falling below expectations due to underperformance in its Clinical Vet Services segment, which constitutes 75% of the company’s revenue. Despite achieving some growth in Intensive Animal Services and implementing efficiency initiatives, the company faced revenue pressures and a statutory net loss following the divestment of Agnes Banks Equine Clinic. In response, a leadership change was made, appointing Bruce Dixon as Interim Managing Director and implementing a Strategic Reset Program to realign the business for sustainable returns.
The most recent analyst rating on (AU:AHX) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on Apiam Animal Health Ltd. stock, see the AU:AHX Stock Forecast page.
More about Apiam Animal Health Ltd.
Apiam Animal Health Ltd. operates in the veterinary services industry, focusing on Clinical Veterinary Services and Intensive Animal Veterinary services. The company provides a network of clinics and specialized services for various animals, with a significant market focus on clinical vet services and intensive animal care.
Average Trading Volume: 397,106
Technical Sentiment Signal: Buy
Current Market Cap: A$158.2M
Learn more about AHX stock on TipRanks’ Stock Analysis page.